Motiper Oral Suspension 5 mg/5 ml

Motiper Oral Suspension is a gastrointestinal medication containing Domperidone Maleate (5 mg/5 ml) manufactured by Mystic Pharmaceuticals Ltd. Priced at ৳28.00 per unit, this oral suspension accelerates gastric emptying and alleviates nausea, vomiting, and reflux symptoms.

Clinically effective for dyspeptic symptoms like abdominal bloating, heartburn, and delayed stomach emptying, Motiper also prevents chemotherapy-induced nausea. Its dopamine-blocking action enhances gastrointestinal motility without crossing the blood-brain barrier, minimizing neurological side effects.

Dosage guidance: Adults take 10-20 mg (10-20 ml) every 6-8 hours before meals. Pediatric doses adjust based on weight (0.2-0.4 mg/kg). Store below 30°C, protected from light. Avoid use in pregnancy unless prescribed.

Common side effects include dry mouth (1.9%) and mild headaches. Rarely, it may cause breast tenderness due to elevated prolactin. Drug interactions with opioids or anticholinergics require medical supervision. Maximum treatment duration: 12 weeks.

For alternatives, explore Domperidone Maleate brands or consult healthcare providers about prokinetic drugs. Mystic Pharmaceuticals ensures quality compliance in this cost-effective solution for digestive disorders.

Adults: 10-20 mg (1-2 teaspoonful) 3-4 times daily. Children: 0.2-0.8 mg/kg body weight. Administer 15-30 mins before meals. Maximum treatment duration: 12 weeks for severe nausea.

Side-effects are rare; exceptionally some transient intestinal cramps have been reported. Extrapyramidal phenomena are rare in young children and exceptional in adults: they reverse spontaneously and completely as soon as the treatment is stopped. As the pituitary gland is located outside the blood-brain barrier, domperidone may induce an increase in the plasma prolactin level. In rare case this hyperprolactinaemia may give rise to neuroendocrinological phenomena such as galactorrhoea and gynaecomastia. When the blood-brain barrier is immature (as in infants) or impaired, the possible occurrence of neurological side-effects cannot be totally excluded. Rare allergic reactions, such as rash and urticaria, have also been reported.

Pregnancy safety unestablished. Compatible with lactation – minimal secretion in breast milk.

Dose reduction needed in hepatic impairment. Monitor prolactin levels during prolonged use. Infants <1 year at risk of neurological effects.

Elderly: Adjust dose for age-related renal decline. Hepatic patients: Max 10 mg/day. Pediatric: Strict weight-based dosing required.

Symptoms of overdosage may include drowsiness, disorientation and extrapyramidal reactions, especially in children. In case of overdosage, the administration of activated charcoal, and close observation of the patients are recommended. Anticholinergic, antiparkinson drugs or antihistamines with anticholinergic properties may be helpful in controlling the extrapyramidal reactions.